Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 5 institutions in 3 countries.
Petr DanielDepartment of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.ORCID 0000-0002-5523-4184
Kamila BalušíkováDepartment of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.ORCID 0000-0002-0471-5877
Radka VáclavíkováToxicogenomics Unit, National Institute of Public Health, 100 00 Prague, Czech Republic.
Karolína ŠeborováToxicogenomics Unit, National Institute of Public Health, 100 00 Prague, Czech Republic.ORCID 0000-0002-8925-2321
Šárka RansdorfováDepartment of Cytogenetics, Institute of Hematology and Blood Transfusion, 128 00 Prague, Czech Republic.
Marie ValeriánováDepartment of Cytogenetics, Institute of Hematology and Blood Transfusion, 128 00 Prague, Czech Republic.
Longfei WeiDepartment of Chemistry, Institute of Chemical Biology & Drug Discovery, Stony Brook University-State University of New York, Stony Brook, NY 11794, USA.
Michael JelínekDepartment of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.
Tereza TlapákováDepartment of Cell Biology, Faculty of Science, Charles University, 128 00 Prague, Czech Republic.ORCID 0000-0001-8841-1573
Thomas FleischerDepartment of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway.ORCID 0000-0003-0985-8460
Vessela N KristensenDepartment of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0424 Oslo, Norway.
Pavel SoučekToxicogenomics Unit, National Institute of Public Health, 100 00 Prague, Czech Republic.ORCID 0000-0002-4294-6799
Iwao OjimaDepartment of Chemistry, Institute of Chemical Biology & Drug Discovery, Stony Brook University-State University of New York, Stony Brook, NY 11794, USA.ORCID 0000-0002-3628-1161
Jan KovářDepartment of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, 100 00 Prague, Czech Republic.ORCID 0000-0001-9432-8960
Charles University · CZInstitute of Haematology and Blood Transfusion · CZState University of New York · USOslo University Hospital · NOUniversity of Oslo · NO
Funding
Tumor -Targeting Chemotherapeutic AgentsR01CA103314 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI OJIMA, IWAO · 2003 to 2013
$3.1M
NCI NIH HHS R01 CA103314
6 · The paper itself
Abstract
A limited number of studies are devoted to regulating
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.